Nathaniel Robinson - Mar 7, 2023 Form 4 Insider Report for Cushman & Wakefield plc (CWK)

Signature
/s/ Brett Soloway, attorney-in-fact
Stock symbol
CWK
Transactions as of
Mar 7, 2023
Transactions value $
$0
Form type
4
Date filed
3/9/2023, 04:10 PM
Previous filing
Mar 7, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CWK Ordinary Shares Options Exercise $0 +4.2K +9.28% $0.00 49.5K Mar 7, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CWK Restricted Stock Units Options Exercise $0 -4.2K -100% $0.00* 0 Mar 7, 2023 Ordinary Shares 4.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan.
F2 RSUs were granted on March 7, 2019 and vested in four (4) substantially equal installments on each of the first four (4) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date. The reporting person has elected to defer settlement of the award until the earlier of January 2024 or termination under the Cushman & Wakefield plc Deferred Compensation Plan.

Remarks:

Chief Investment Officer and Executive Vice President of Strategic Planning